3 recruiting. 3 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Recruiting 3 |
| Phase 1 | 1 | Recruiting 1 |
Follow Myxofibrosarcoma: new trials by email Literature Review of Myxofibrosarcoma trials Research Report on Myxofibrosarcoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Dose-escalated, Hypofractionated, Definitive Proton Radiotherapy for Patients With Inoperable Soft Tissue Sarcoma. Definitive radiotherapy - Soft Tissue Sarcoma (STS), Soft Tissue Sarcoma Adult | Phase 2 | Recruiting | Oslo University Hospital | 40 | 2026-01-26 | 2026-01-28 |
| NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS) Surgical resection, Proton beam radiation therapy, Pazopanib - Adipocytic Neoplasm, Liposarcoma | Phase 1 / Phase 2 | Recruiting | St. Jude Children's Research Hospital | 139 | 2024-03-27 | 2026-08-03 |
| A Study of Pembrolizumab Plus Local Chemotherapy Using Isolated Limb Infusion (ILI) for Patients With Sarcoma in the Arm or Leg Isolated Limb Infusion, Pembrolizumab, infusion of melphalan and dactinomycin - Sarcoma, Myxofibrosarcoma | Phase 2 | Recruiting | Memorial Sloan Kettering Cancer Center | 30 | 2020-04-01 | 2026-04-23 |
Dermatofibrosarcoma (3) · Sarcoma (3) · Histiocytoma, Malignant Fibrous (2) · Leiomyosarcoma (2) · Liposarcoma (2) · Sarcoma, Synovial (2) · Chondrosarcoma, Extraskeletal Myxoid (1) · Disorders of Sex Development (1) · Fibrosarcoma (1) · Glomus Tumor (1) · Granular Cell Tumor (1) · Hemangioendothelioma, Epithelioid (1) · Hemangiosarcoma (1) · Histiocytoma, Angiomatoid Fibrous (1) · Liposarcoma, Myxoid (1)
Neoplasms (3) · Neoplasms by Histologic Type (3) · Neoplasms, Connective Tissue (3) · Neoplasms, Connective and Soft Tissue (3) · Neoplasms, Fibrous Tissue (3) · Neoplasms, Muscle Tissue (3) · Fibrosarcoma (2) · Histiocytoma (2) · Congenital Abnormalities (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Endocrine System Diseases (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Gonadal Disorders (1) · Hemangioendothelioma (1)
Dactinomycin (1) · Doxorubicin (1) · Ifosfamide (1) · Proton Therapy (1) · pazopanib (1) · pembrolizumab (1) · selinexor (1)
Memorial Sloan Kettering Cancer Center (1) · Oslo University Hospital (1) · St. Jude Children's Research Hospital (1)
United States (2) · Norway (1)
Edmund Bartlett, MD (1) · Ivar Hompland, MD, PhD (1) · Jessica Gartrell, MD (1) · Kjetil Boye, MD, PhD (1)